In a phase 3 randomised self-controlled trial of 50 patients starting regorafenib or sorafenib, adding hydrocolloid dressing to moisturiser lowered grade ≥2 hand-foot skin reaction of the soles versus moisturiser alone (20% vs 50%; p<0.0001).
RCTn = 50
Ryu et al. Efficacy of hydrocolloid dressing for hand-foot skin reaction: J-SUPPORT 1701 APRON trial